InvestSMART

BPH Energy Ltd (ASX: BPH) - Announcements

- Current share price for BPH : $0.003

ASX company news and announcements for BPH Energy Ltd (BPH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BPH Energy Ltd (BPH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BPH Energy Ltd (BPH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BPH Energy Ltd (BPH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Uni California Expert to Work with MDS on Image Analysis 24 May 2006 12:37PM $0.130 $0.003 fallen by 97.69%
$4 Successful Brain Function Monitor Results 16 May 2006 10:43AM $0.150 $0.003 fallen by 98%
$4 Commitments Test Entity - Third Quarter Report 27 Apr 2006 5:59PM $0.150 $0.003 fallen by 98%
$4 Launch of Molecular Discovery Systems 12 Apr 2006 8:29AM $0.170 $0.003 fallen by 98.24%
$4 Half Yearly Report & Half Year Accounts 17 Mar 2006 8:29AM $0.165 $0.003 fallen by 98.18%
$4 Successful Lung Disease Genechip Trial 1 Feb 2006 11:40AM $0.260 $0.003 fallen by 98.85%
$4 Commitments Test Entity - Second Quarter Report 1 Feb 2006 8:31AM $0.260 $0.003 fallen by 98.85%
$4 HLS5 Gene implicated in Huntingtons and AIDS 18 Jan 2006 9:55AM $0.210 $0.003 fallen by 98.57%
$4 Australian Bacterial DNA Test Success 20 Dec 2005 12:45PM $0.180 $0.003 fallen by 98.33%
$4 Commitments Test Entity - First Quarter Report 31 Oct 2005 4:54PM $0.080 $0.003 fallen by 96.25%
$4 BAR Monitor Validation Trials 30 Sep 2005 10:54AM n/a $0.003 n/a
$4 HLS5 Gene Project Update 29 Sep 2005 9:42AM n/a $0.003 n/a
$4 Preliminary Final Report 2005 14 Sep 2005 8:30AM n/a $0.003 n/a
$4 Commitments Test Entity - Fourth Quarter Report 29 Jul 2005 3:09PM n/a $0.003 n/a
$4 BAR System Passes International EMC Testing 18 Mar 2005 1:39PM n/a $0.003 n/a
$4 Supplementary Disclosure Document 22 Dec 2004 8:30AM $0.195 $0.003 fallen by 98.46%
$4 Shareholder Share Purchase Plan 17 Dec 2004 8:20PM $0.200 $0.003 fallen by 98.50%
$4 Federal Gov Funds DAS Project 4 Nov 2004 2:23PM $0.200 $0.003 fallen by 98.50%
$4 Brain Science Company Signs With BioPharmica 27 Sep 2004 10:27AM $0.212 $0.003 fallen by 98.59%
$4 Options Issue for BioPharmica Shareholders 10 Sep 2004 10:41AM $0.177 $0.003 fallen by 98.30%
$4 Prototype & Pilot Test 6 Sep 2004 12:34PM $0.168 $0.003 fallen by 98.21%
$4 Admission to Official List 4 Aug 2004 6:57PM n/a $0.003 n/a

1076 - 1097 of 1097 results

Page 44 of 44

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.